NCT01863459: Lisdexamfetamine Dimesylate in the Treatment of Adult ADHD With Anxiety Disorder Comorbidity |
|
|
| Completed | 4 | 42 | Canada | Lisdexamfetamine Dimesylate, Vyvanse, placebo | Centre for Anxiety, Attention Deficit and Trauma, Ontario, Canada, Shire | Adult Attention Deficit Hyperactivity Disorder (ADHD) With Co-occuring Anxiety and Depressive Disorders | 03/17 | 03/17 | | |